Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Therapeutic application of neuro-stimulation in acute dysphagic stroke
ISRCTN ISRCTN83103698
ClinicalTrials.gov identifier
Public title Therapeutic application of neuro-stimulation in acute dysphagic stroke
Scientific title A randomised controlled trial of pharyngeal electrical stimulation in the treatment of dysphagia after brain injury
Acronym N/A
Serial number at source G108/374
Study hypothesis Establish efficacy of pharyngeal stimulation in accelerating swallowing recovery after acute dysphagic stroke.

Please note that, as of 22/07/2008, the start and end dates of this trial have been updated from 01/09/2003 and 31/08/2005 to 08/11/2005 and 31/11/2013, respectively.

Please note that the scientific title was added as of 19/10/2009.
Lay summary
Ethics approval Salford and Trafford Research Ethics Committee (ref: 00167). Original ethics approval date: 01/10/2002. An ethics amendment for the current phase of the study was approved on 08/11/2005.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Acute dysphagic stroke
Participants - inclusion criteria Current inclusion criteria as of 05/09/2008:
Any patient with first event of an anterior circulation stroke (both males and females, no age limits). Patients are recruited within 3 weeks of their admission with stroke. Videofluoroscopy is carried out to determine the degree of airway penetration/aspiration.

Previous inclusion criteria:
Hemispheric stroke and dysphagia
Participants - exclusion criteria 1. Inability to give informed consent
2. Serious inter-current illness
3. Major neuromuscular modulating drugs
4. Other neurological diseases
5. Previous dysphagia
Anticipated start date 08/11/2005
Anticipated end date 30/11/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 80
Interventions Current interventions as of 05/09/2008:
Subjects are randomised to receive either real or sham pharyngeal electrical stimulation at low frequency. The intensity of the electrical stimulation is determined following the calculation of suitable sensory threshold, tailored to the individual participants. Subjects receive the intervention 3 times in a week, within a few days following index videofluoroscopy.

Previous interventions:
Real versus sham stimulation

Previous sponsor for this trial (from 01/09/2005 to 31/01/2008) was:
Medical Research Council (UK)
20 Park Crescent
London
W1B 1AL
United Kingdom
Primary outcome measure(s) Current primary outcome measures as of 05/09/2008:
Penetration-aspiration score and swallowing response time, assessed by videofluoroscopy at baseline and 2 weeks after the intervention.

Previous primary outcome measures:
1. Mortality
2. Aspiration pneumonia
3. Swallowing function assessed by videofluoroscopy
Secondary outcome measure(s) Added as of 05/09/2008:
1. Aspiration pneumonia rates
2. Usage of antibiotics for chest infections
3. Hospital stays
4. Readmission rates
5. Mortality

Total duration of follow-up: 6 months
Sources of funding Current source of funding as of 15/10/2009:
National Institute of Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB)

Current sources of funding as of 22/07/2008:
1. Action Medical Research (UK) (until April 2009)
2. National Institute of Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB)

Previous sources of funding:
1. Medical Research Council (UK)
2. The Health Foundation (UK) (ref: 1727/1793)
Trial website
Publications 1. 2005 abstract from Annual Meeting of the American Gastroenterological Association/Digestive Disease Week: http://www.ncbi.nlm.nih.gov/pubmed/15900640
2. 2006 abstract from Annual Meeting of the British Society of Gastroenterology: http://www.ncbi.nlm.nih.gov/pubmed/16531518
Contact name Dr  S  Hamdy
  Address GI Sciences
Hope Hospital
Eccles Old Road
  City/town Salford
  Zip/Postcode M6 8HD
  Country United Kingdom
  Tel +44 (0)161 787 4414
  Fax +44 (0)161 787 1495
  Email Shaheen.hamdy@manchester.ac.uk
Sponsor University of Manchester (UK)
  Address University Research Office
2nd Floor Chrisie Building
University of Manchester
Oxford Road
  City/town Manchester
  Zip/Postcode M13 9PL
  Country United Kingdom
  Sponsor website: http://www.manchester.ac.uk
Date applied 07/01/2003
Last edited 19/10/2009
Date ISRCTN assigned 07/01/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central